Article Details

UPDATE 1-Lilly's COVID-19 drug reduces death risk in patients on mechanical ventilation

Retrieved on: 2021-08-03 10:30:00

Tags for this article:

Click the tags to see associated articles and topics

UPDATE 1-Lilly's COVID-19 drug reduces death risk in patients on mechanical ventilation. View article details on hiswai:

Excerpt

The U.S. Food and Drug Administration (FDA) first approved Lilly's arthritis drug, baricitinib, in combination with Gilead Sciences' remdesivir, to treat ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up